Carla Maria Canuso
Vice President, Head of Neuropsychiatry Clinical Development at Janssen Research & Development, LLC
Papers
Trials
Key Impact
She is a leading industry psychiatrist who helped drive clinical development of esketamine for treatment-resistant depression and suicidal ideation, shaping a major modern psychedelic-adjacent psychiatric treatment program.
Background & Research
Carla M. Canuso, M.D. is a psychiatrist and drug-development leader at Janssen Research & Development. Her CV lists her current role as Vice President, Head of Neuropsychiatry Clinical Development, and her prior work leading the SPRAVATO (esketamine) development program for treatment-resistant depression and major depression with suicidal ideation. She earned her M.D. from the Medical College of Pennsylvania and completed psychiatry residency at the University of Chicago, followed by fellowship training in schizophrenia research.
Collaboration Network
9 collaborators· click a node to visit their profile
Full network →